Contract HHSD200200928832I
Medimmune Llc · Department Of Health And Human Services · March 16, 2009
Medimmune Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 16, 2009 for $61.89 million of work in biological product (except diagnostic) manufacturing. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 8, 2017.
Contract details
- PIID
- HHSD200200928832I
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 16, 2009
- Latest action
- September 8, 2017
Description
MEDIMMUNE VFC FLU 2009
Modification timeline
-
September 8, 2017Mod 11$0
-
July 5, 2012Mod 10$0
-
December 9, 2010Mod 9$-2.8K
-
November 10, 2009Mod 8$289.8K
-
October 30, 2009Mod 7$2.07M
-
August 31, 2009Mod 6$0
-
August 18, 2009Mod 5$-7.37M
-
August 4, 2009Mod 4$0
-
June 8, 2009Mod 3$10.08M
-
May 28, 2009Mod 1$1.52M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200200928832I?
Contract HHSD200200928832I is a federal contract awarded to Medimmune Llc by Department Of Health And Human Services on March 16, 2009 for $61.89 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 11 times since the base award.
Who won contract HHSD200200928832I?
Medimmune Llc won contract HHSD200200928832I from Department Of Health And Human Services.
How much is contract HHSD200200928832I worth?
Contract HHSD200200928832I has obligated $61.89 million to date.